AI/ML Innovations Inc. Appoints Peter Kendall as President and Chief Commercialization Officer

AI/ML Innovations Inc. has announced the appointment of Peter Kendall as its new President and Chief Commercialization Officer, effective January 6, 2025. Kendall, who has held leadership roles at TELUS Health, Medisys, Lifemark, and 3M, brings significant expertise in revenue generation and strategic planning.

Kendall's appointment aligns with AIML's strategic vision to expand its footprint in the health tech industry globally. His track record in scaling businesses and optimizing operations positions him to lead AIML towards impactful growth and innovation.

Kendall's compensation includes a mix of cash and shares, totaling $120,000, along with stock options for 2,500,000 shares. The shares and options are subject to the necessary regulatory approvals.